Susunod

Auto-play

Emerging Agents in the Pipeline for Merkel Cell Carcinoma

3 Mga view • 07/17/23
Ibahagi
I-embed
administrator
administrator
Mga subscriber
0

Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, discusses emerging agents in the pipeline for Merkel cell carcinoma.

Magpakita ng higit pa
0 Mga komento sort Pagbukud-bukurin Ayon
Mga Komento sa Facebook

Susunod

Auto-play